藥 物 回 收
|
| |
| Singapore: Recall of Marcain Injection 0.5% (4ml) (Bupivacaine) (English only) |
| |
Health Sciences Authority (HSA) announces that DCH Auriga Singapore is recalling one batch of Marcain Injection 0.5% (4ml) (bupivacaine) (batch number: F0083-1) to the retail level due to possibility of Marcain Spinal Heavy Injection 0.5% ampoules being packed in the blister packaging for Marcain Injection 0.5%.
Marcain Injection 0.5% is indicated for the production of spinal anaesthesia.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-marcain-injection-0.5--(4ml)-(bupivacaine)
In Hong Kong, Marcain Injection 0.5% (4ml) is not a registered pharmaceutical product.
Ends/Tuesday, Jan 27, 2026
Issued at HKT 18:30
|
| |
